Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04649047
Other study ID # 2020B0322
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date June 30, 2024

Study information

Verified date June 2023
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This lifestyle behavior intervention aims to weight loss in low-income overweight or obese mothers of young children through promotion of stress management, healthy eating, and physical activity. All eligible women will be assigned to the intervention group. The intervention will last 3 weeks and will be delivered via weekly web and individual health coaching sessions.


Description:

Previous research in lifestyle behavior weight loss intervention has 3 limitations. (1) Low-income overweight or obese mothers of young children have been significantly underrepresented. (2) Prior lifestyle interventions in overweight or obese mothers have suffered from threats to internal validity and have not specifically addressed motivation, emotion, and cognition (especially executive function), all of which are critical for promoting and maintaining healthy lifestyle behaviors and health outcomes. (3) There has been little evidence that any of the potentially efficacious strategies researched previously were even possible under real-world conditions. The proposed small pilot study builds on strength and effectively addresses limitations of prior research. The ultimate goal of the proposed study is to create a more feasible and scalable intervention that can be easily implemented and sustained in real-world settings. This self-directed, web-based goal-oriented episodic future thinking intervention will focus on increasing motivation (autonomous motivation and self-efficacy) and improving emotion (emotion control and stress) and cognition (impulsivity). the will lead to weight loss and decrease risk of chronic conditions associated with obesity, for example, hypertension, type 2 diabetes, and cancer. All eligible women will be assigned to the intervention group. The intervention will last 3 weeks and will be delivered via weekly web and individual health coaching sessions. We will enroll 30 low-income overweight or obese mothers of young children with diverse racial and ethnic backgrounds. All participants will be assessed at baseline (T1) and immediately after the three-week intervention (T2). Specific aims are to to (1) assess intervention fidelity (dose, delivery, receipt) and acceptability by the study participants, (2) investigate potential intervention impact on the primary (body weight) and secondary outcomes (waist circumference), (3) explore potential intervention impact on lifestyle behaviors (diet and physical activity), (4) explore potential intervention impact on motivation (autonomous motivation, self-efficacy, social support), emotion (emotion control, stress), and cognition (impulsivity), and (5) assess cost of different recruitment approaches.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date June 30, 2024
Est. primary completion date December 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Body mass index of 25.0-39.9 kg/m2 (calculated using height and weight) - Current enrollment in government assistant programs (for example, WIC, food stamp (SNAP), or Madicaid) - 6 weeks - 3.5 years postpartum - 18-45 years old - Fluency in speaking, reading, and writing English - Ownership of a smart phone with unlimited text messages and internet access - Committed to a three-week intervention study Exclusion Criteria: - Current pregnancy or lactation - Plan to become pregnant during the trial - Type 1 or 2 diabetes - Untreated thyroid disease - Drug or alcohol abuse or dependence within last six months - Major psychiatric disorder (e.g., schizophrenia, bipolar) - History of bulimia or anorexia - Current taking of appetite suppressant or (antipsychotic) medications known to affect body weight - Current participation in a weight control or drug study - Current or planned participation in a commercial weight loss program - Previous weight loss surgery - Contraindications to physical activity

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Goal-oriented episodic future thinking
All participants will receive a 3-week web-based intervention plus individual health coaching. The intervention topics include stress management, healthy eating, and physical activity

Locations

Country Name City State
United States The Ohio State University Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight Self-reported body weight baseline (T1) and 3 weeks follow up (T2)
Secondary Waist circumference Self-reported pants size will be used to measure waist circumference. Participants will report their current pants size. Values are: 00-0 = extra small, 2-4 = small, 6-8 = medium, 10-12 = large,14-16 = extra large, 18-20 = 2XL, 22-24 =3XL. Higher scores indicate higher waist circumference. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in dietary fat intake The NCI brief dietary fat intake survey (16 items) will be used to measure dietary fat intake. Participants will be asked to report the frequency of each specific food that they eat over the past 12 months. Values are:1 = never, 2 = less than once per month,3 = 1-3 times per week, 4 = 3-4 times per week,5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 or more times per day. Higher scores indicate more frequent fat intake. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in fruit and vegetable intake The NCI brief fruit and vegetable intake survey (9 items) will be used to measure fruit and vegetable intake. Participants will be asked to report frequency of each specific fruit and vegetable that they eat over the past month. Values are:1 = never, 2 = 1-3 times last month,3 = 1-2 times per week, 4 = 3-4 times per week, 5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 times per day, 8 = 3 times per day, 9 = 4 times per day, 10 = 5 or more times per day. Higher scores indicate more frequent fruit and vegetable intake. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in added sugar intake The NCI five-factor screener (4 items) will be used to measure added sugar intake. Participants will be asked to report frequency of each specific soda beverages that they drink over the past month. Values are:1 = never, 2 = 1-3 times last month,3 = 1-2 times per week, 4 = 3-4 times per week, 5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 times per day, 8 = 3 times per day, 9 = 4 times per day, 10 = 5 or more times per day. Higher scores indicate more frequent added sugar intake. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in physical activity The International Physical Activity Questionnaire Short Form (7 items) will be used to measure physical activity. Participants will be asked to report frequency (days/week) and duration (hours/ day or minutes/day) of vigorous and moderate physical activities that they did in the past 7 days. Higher scores indicate more physical activity. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in autonomous motivation for stress management The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for stress management. Participants will be asked to report why they manage stress.
Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for stress management.
baseline (T1) and 3 weeks follow up (T2)
Secondary Change in autonomous motivation for healthy eating The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for healthy eating. Participants will be asked to report why they eat healthier foods.
Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for healthy eating.
baseline (T1) and 3 weeks follow up (T2)
Secondary Change in autonomous motivation for physical activity The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for physical activity. Participants will be asked to report why they want to be physically active. Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for physical activity. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in coping self-efficacy Survey for coping self-efficacy (10 items) will be used to measure coping self-efficacy. Participants will be asked to report their confidence in coping stress. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident. Higher scores indicate higher coping self-efficacy. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in healthy eating self-efficacy Survey for healthy eating self-efficacy (8 items) will be used to measure healthy eating self-efficacy. Participants will be asked to report their confidence in eating healthier. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident.
Higher scores indicate higher healthy eating self-efficacy.
baseline (T1) and 3 weeks follow up (T2)
Secondary Change in physical activity self-efficacy Survey for healthy eating self-efficacy (10 items) will be used to measure physical activity self-efficacy. Participants will be asked to report their confidence in more physically active. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident. Higher scores indicate higher physical activity self-efficacy. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in social support for stress management A survey (6 items) will be used to measure social support for stress management. The survey assess how often participants asking for family members, friends, co-worker or other people for support when they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for stress management. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in social support for healthy eating A survey (5 items) will be used to measure social support for healthy eating. The survey assess how often participants asking for family members, friends, co-worker or other people for support they they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for healthy eating. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in social support for physical activity A survey (4 items) will be used to measure social support for healthy eating. The survey assess how often participants asking for family members, friends, co-worker or other people for support they they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for physical activity. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in emotion regulation Emotion Regulation Questionnaire (10 items) will be used to assess emotion regulation. This questionnaire assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 sub scales: reappraisal (6 items) and suppression (4 items). Values are 1 = strongly disagree, 2 = mostly disagree, 3 =somewhat disagree, 4= neither agree or disagree, 5 = somewhat agree, 6 = mostly agree, 7 = strongly agree. Higher scores indicate higher reappraisal or suppression. baseline (T1) and 3 weeks follow up (T2)
Secondary Change in perceived stress The perceived stress scale (10 items) will be used to measure perceived stress. This survey measures the degree to which situations in one's life are appraised as stressful.
Values are 0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4= very often Higher scores indicate higher levels of perceived stress.
baseline (T1) and 3 weeks follow up (T2)
Secondary Change in impulsiveness The Barratt Impulsiveness scale (30 items) will be used to measure impulsiveness. This survey measures the degree to which situations in one's life are appraised as stressful.
Values are 1 = never, 2 = rarely, 3 = almost always, 4= always. Higher scores indicate less impulsiveness.
baseline (T1) and 3 weeks follow up (T2)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2